Table 4 Survival on breast IMPC and IDC in previous seven reports and the present study
Author | Median follow-up (month) | OS (IMPC vs IDC) | FFS (IMPC vs IDC) | LRFS (IMPC vs IDC) | DMFS (IMPC vs IDC) |
|---|---|---|---|---|---|
Chen [4] | 60.1 | 59 vs 77 % P = 0.004 | / | 88.8 vs 96 % P = 0.055 | 61.2 vs 72 % P = 0.108 |
Yu [8] | 45.0 | 86 vs 87.7 % P = 0.18 | / | 68.2 vs 81.4 % P = 0.045 | 78.1 vs 79.3 % P = 0.86 |
Vingiani [14] | 51.0 | 89.8 vs 90.8 % P = 0.8 | 75.5 vs 79.6 % P = 0.47 | / | / |
Liu [9] | 68.4 | / | 84.3 vs 78.4 % P = 0.518 | / | / |
Shi [7] | 40.5 | 75.9 vs 89.5 % P = 0.001 | 67.1 vs 84.5 % P < 0.001 | / | / |
Chen [10] | 48.0 | 82.9 vs 80.5 % P = 0.52 | / | / | / |
Yu [16] | 59.0 | 97.7 vs 95.7 % P = 0.67 | / | 91.8 vs 96.3 % P = 0.03 | / |
Present study | 39.0 | 97 vs 94.2 % P = 0.78 | 87.9 vs 86.2 % P = 0.91 | 93.9 vs 89.0 % P = 0.82 | 90.9 vs 89 % P = 0.97 |